Kate Bingham

Dame Kate Bingham served as the Chair of the UK Vaccine Taskforce, steering a team of experts to deliver the world’s fastest Covid-19 vaccination programme. She is a Managing Partner at SV Health Investors, where she co-leads SV’s biotech franchise. SV’s investments have resulted in the launch of twenty drugs for inflammatory and autoimmune disease, blindness and cancer. Kate is a board member of the Francis Crick Institute and helped launch the Dementia Discovery Fund – the largest fund ever to develop treatments for the disease.